Jennison Associates’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,309
| Closed | -$377K | – | 725 |
|
|
2019
Q4 | $377K | Buy |
+15,309
| New | +$377K | ﹤0.01% | 603 |
|
|
2019
Q2 | – | Sell |
-710,156
| Closed | -$8.8M | – | 684 |
|
|
2019
Q1 | $8.8M | Sell |
710,156
-1,166,839
| -62% | -$14.5M | 0.01% | 436 |
|
|
2018
Q4 | $11.6M | Sell |
1,876,995
-324,042
| -15% | -$2M | 0.01% | 418 |
|
|
2018
Q3 | $23.3M | Buy |
2,201,037
+16,249
| +0.7% | +$172K | 0.02% | 372 |
|
|
2018
Q2 | $29.6M | Buy |
2,184,788
+36,762
| +2% | +$498K | 0.03% | 345 |
|
|
2018
Q1 | $38.1M | Buy |
2,148,026
+272,498
| +15% | +$4.84M | 0.04% | 292 |
|
|
2017
Q4 | $23.5M | Buy |
1,875,528
+7,867
| +0.4% | +$98.7K | 0.02% | 373 |
|
|
2017
Q3 | $35.6M | Sell |
1,867,661
-9,474
| -0.5% | -$180K | 0.04% | 315 |
|
|
2017
Q2 | $28.3M | Sell |
1,877,135
-56,669
| -3% | -$856K | 0.03% | 346 |
|
|
2017
Q1 | $33.2M | Hold |
1,933,804
| – | – | 0.04% | 339 |
|
|
2016
Q4 | $23.4M | Buy |
1,933,804
+184,069
| +11% | +$2.23M | 0.03% | 392 |
|
|
2016
Q3 | $17.2M | Sell |
1,749,735
-28,940
| -2% | -$285K | 0.02% | 430 |
|
|
2016
Q2 | $18.2M | Buy |
1,778,675
+12,863
| +0.7% | +$132K | 0.02% | 407 |
|
|
2016
Q1 | $21.4M | Buy |
1,765,812
+871,899
| +98% | +$10.6M | 0.02% | 395 |
|
|
2015
Q4 | $14.3M | Buy |
893,913
+640,245
| +252% | +$10.3M | 0.01% | 451 |
|
|
2015
Q3 | $3.26M | Buy |
253,668
+1,551
| +0.6% | +$19.9K | ﹤0.01% | 553 |
|
|
2015
Q2 | $6.05M | Buy |
252,117
+1,979
| +0.8% | +$47.5K | 0.01% | 521 |
|
|
2015
Q1 | $4.7M | Buy |
+250,138
| New | +$4.7M | ﹤0.01% | 517 |
|